...
首页> 外文期刊>Diabetes care >Contribution of insulin-stimulated glucose uptake and Basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity.
【24h】

Contribution of insulin-stimulated glucose uptake and Basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity.

机译:胰岛素刺激的葡萄糖摄取和基础肝胰岛素敏感性对胰岛素敏感性替代指标的贡献。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE-The goal of this study was to evaluate the performance of surrogate measures of insulin sensitivity and insulin secretion. RESEARCH DESIGN AND METHODS-The homeostasis model assessment (HOMA) of insulin resistance (IR) and the insulin sensitivity index (S(i)) from oral glucose tolerance test (OGTT) were compared with the M value from a hyperinsulinemic-euglycemic clamp in 467 subjects with various degrees of glucose tolerance. Endogenous glucose production (EGP) and hepatic insulin sensitivity were determined in a subset (n = 143). Insulin secretion was estimated as the HOMA beta-cell index and as the insulinogenic index from the first 30 min of the OGTT (I/G30) and compared with the first-phase insulin response (FPIR) to an intravenous glucose tolerance test (n = 218). RESULTS-The M value correlated with the HOMA-IR (r = -0.591, P < 0.0001) and the S(i) (r = 0.533, P < 0.0001) indexes in the total study group. HOMA-IR correlated with basal EGP in the total study group (r = 0.378, P < 0.0005) and in subjects with diabetes (r = 0.330, P = 0.01). However, neither HOMA-IR nor S(i) correlated significantly with the M value in subjects with impaired fasting glucose (IFG) (r = -0.108, P = 0.5; r = 0.01, P = 0.9) or IFG/impaired glucose tolerance (IGT) (r = -0.167, P = 0.4; r = 0.09, P = 0.6). The HOMA-IR correlated with hepatic insulin sensitivity in the whole study group (r = -0.395, P < 0.005) as well as in the IFG/IGT subgroup (r = -0.634, P = 0.002) and in the diabetic subgroup (r = -0.348, P = 0.008). In subjects with IFG/IGT, hepatic insulin sensitivity was the most important determinant of HOMA-IR, explaining 40% of its variation. The HOMA beta-cell index showed a weak correlation with FPIR in the whole study group (r = 0.294, P = 0.001) but not in the subgroups. In contrast, the I/G30 correlated with FPIR in the whole study group (r = 0.472, P < 0.0005) and in the IFG/IGT subgroup (r = 0.493, P < 0.005). CONCLUSIONS-HOMA-IR is dependent upon both peripheral and hepatic insulin sensitivity, the contribution of which differs between subjects with normal and elevated fasting glucose concentrations. These discrepancies develop as a consequence of a nonparallel deterioration of the variables included in the equations with worsening of glucose tolerance.
机译:目的-本研究的目的是评估胰岛素敏感性和胰岛素分泌的替代指标。研究设计和方法-将口服葡萄糖耐量试验(OGTT)的胰岛素抵抗(IR)稳态模型评估(HOMA)和胰岛素敏感性指数(S(i))与高胰岛素-正常血糖钳夹的M值进行比较467位不同程度的葡萄糖耐量受试者。在一个子集中确定了内源性葡萄糖生成(EGP)和肝胰岛素敏感性(n = 143)。从OGTT的前30分钟(I / G30)起,将胰岛素分泌估计为HOMAβ细胞指数和致胰岛素指数,并将其与第一阶段胰岛素反应(FPIR)进行静脉葡萄糖耐量测试(n = 218)。结果-在整个研究组中,M值与HOMA-IR(r = -0.591,P <0.0001)和S(i)(r = 0.533,P <0.0001)指数相关。在整个研究组(r = 0.378,P <0.0005)和糖尿病患者(r = 0.330,P = 0.01)中,HOMA-IR与基础EGP相关。然而,空腹血糖受损(IFG)(r = -0.108,P = 0.5; r = 0.01,P = 0.9)或IFG /糖耐量受损的受试者中,HOMA-IR和S(i)均与M值均无显着相关。 (IGT)(r = -0.167,P = 0.4; r = 0.09,P = 0.6)。在整个研究组(r = -0.395,P <0.005)以及IFG / IGT亚组(r = -0.634,P = 0.002)和糖尿病亚组(r)中,HOMA-IR与肝胰岛素敏感性相关= -0.348,P = 0.008)。在患有IFG / IGT的受试者中,肝胰岛素敏感性是HOMA-IR的最重要决定因素,可解释其40%的变异。在整个研究组中,HOMAβ细胞指数与FPIR相关性较弱(r = 0.294,P = 0.001),但在亚组中则没有。相反,在整个研究组(r = 0.472,P <0.0005)和IFG / IGT亚组中,I / G30与FPIR相关(r = 0.493,P <0.005)。结论-HOMA-IR依赖于外周和肝胰岛素敏感性,空腹血糖浓度正常和升高的受试者之间的贡献是不同的。这些差异的产生是由于方程式中包含的变量的非平行恶化以及葡萄糖耐量的恶化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号